BioNTech SE - American Depositary Shares — 재무제표 (NASDAQ:BNTX)

Financials

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

BNTX

Financials

BioNTech SE - American Depositary Shares

뉴스

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Bristol-Myers Squibb Is Quietly Building Its Next Growth Cycle (NYSE:BMY)

Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?

BNTX Stock News: BioNTech Announces Layoffs as Covid-19 Revenue Slides

BioNTech SE (BNTX) Q1 2026 Earnings Call Transcript

Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth

Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings

Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

BioNTech (BNTX) Surges 6.1%: Is This an Indication of Further Gains?

Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings

US judge blocks efforts to reshape childhood vaccine policy